29 related articles for article (PubMed ID: 19816521)
1. PRDM16 suppresses HIF-targeted gene expression in kidney cancer.
Kundu A; Nam H; Shelar S; Chandrashekar DS; Brinkley G; Karki S; Mitchell T; Livi CB; Buckhaults P; Kirkman R; Tang Y; Rowe GC; Wei S; Varambally S; Sudarshan S
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32251515
[TBL] [Abstract][Full Text] [Related]
2. HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl
Magdaleno C; Dixon L; Rajasekaran N; Varadaraj A
Sci Rep; 2020 Oct; 10(1):18560. PubMed ID: 33122751
[TBL] [Abstract][Full Text] [Related]
3. Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines.
Pasha M; Sivaraman SK; Frantz R; Agouni A; Munusamy S
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30909494
[TBL] [Abstract][Full Text] [Related]
4. Potential Applications of Nanotechnology in Urological Cancer.
He MH; Chen L; Zheng T; Tu Y; He Q; Fu HL; Lin JC; Zhang W; Shu G; He L; Yuan ZX
Front Pharmacol; 2018; 9():745. PubMed ID: 30038573
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis.
Li ML; Xu YZ; Lu WJ; Li YH; Tan SS; Lin HJ; Wu TM; Li Y; Wang SY; Zhao YL
Oncol Lett; 2018 Mar; 15(3):2839-2846. PubMed ID: 29435010
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference.
Choi SH; Park JY
Cancer Cell Int; 2017; 17():3. PubMed ID: 28053598
[TBL] [Abstract][Full Text] [Related]
7. WSB1 promotes tumor metastasis by inducing pVHL degradation.
Kim JJ; Lee SB; Jang J; Yi SY; Kim SH; Han SA; Lee JM; Tong SY; Vincelette ND; Gao B; Yin P; Evans D; Choi DW; Qin B; Liu T; Zhang H; Deng M; Jen J; Zhang J; Wang L; Lou Z
Genes Dev; 2015 Nov; 29(21):2244-57. PubMed ID: 26545811
[TBL] [Abstract][Full Text] [Related]
8. The role of HIF1α in renal cell carcinoma tumorigenesis.
Gudas LJ; Fu L; Minton DR; Mongan NP; Nanus DM
J Mol Med (Berl); 2014 Aug; 92(8):825-36. PubMed ID: 24916472
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells.
Zhang J; Guo H; Zhu JS; Yang YC; Chen WX; Chen NW
Oncol Lett; 2014 May; 7(5):1401-1408. PubMed ID: 24765145
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.
Tian D; Sun Y; Yang Y; Lei M; Ding N; Han R
Onco Targets Ther; 2013; 6():419-26. PubMed ID: 23723709
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
Tamaki Y; Nakade Y; Yamauchi T; Makino Y; Yokohama S; Okada M; Aso K; Kanamori H; Ohashi T; Sato K; Nakao H; Haneda M; Yoneda M
J Gastroenterol; 2013 Apr; 48(4):491-503. PubMed ID: 22886508
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.
Conley SJ; Gheordunescu E; Kakarala P; Newman B; Korkaya H; Heath AN; Clouthier SG; Wicha MS
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2784-9. PubMed ID: 22308314
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation.
Bohonowych JE; Peng S; Gopal U; Hance MW; Wing SB; Argraves KM; Lundgren K; Isaacs JS
BMC Cancer; 2011 Dec; 11():520. PubMed ID: 22172030
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia, stem cells and bone tumor.
Zeng W; Wan R; Zheng Y; Singh SR; Wei Y
Cancer Lett; 2011 Dec; 313(2):129-36. PubMed ID: 21999934
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma.
Xu Z; Shen G; Xia X; Zhao X; Zhang P; Wu H; Guo Q; Qian Z; Wei Y; Liang S
J Transl Med; 2011 Apr; 9():46. PubMed ID: 21513541
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis.
Xu K; Ding Q; Fang Z; Zheng J; Gao P; Lu Y; Zhang Y
Cancer Gene Ther; 2010 Mar; 17(3):212-22. PubMed ID: 19816521
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
19. [Effect of silencing hypoxia-inducible factor-1 alpha by RNA interference on human breast carcinoma cell line].
Wang H; Liu YJ; Han ZB; Liang LH; Lv LL; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):670-4. PubMed ID: 17121229
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
